N. Taibulatov

[Efficiency and safety of human monoclonal antibodies to TNF-alpha in children with juvenile idiopathic arthritis in primary and secondary ineffectiveness of other biologicals].

E. Alexeeva, A. Baranov, E. Zelikovich, 2013, Vestnik Rossiiskoi akademii meditsinskikh nauk.

Efficacy and Safety of Adalimumab Long-Term Administration with Immunosuppressants at Juvenile Idiopathic Arthritis without Systemic Manifestations

E. Alexeeva, T. Sleptsova, S. Valieva, 2016 .

Predictors of the response to etanercept in patients with juvenile idiopathic arthritis without systemic manifestations within 12 months: results of an open-label, prospective study conducted at the National Scientific and Practical Center of Children's Health, Russia

E. Alexeeva, A. Baranov, L. Namazova-Baranova, 2017, Pediatric Rheumatology.